Loading... please wait

Now is the Time: Last Mile Challenges to Close the Global Health Equity Gaps for Children

Speakers:

Daniel Diasio, Global Consulting AI Leader, Ernst & Young
Chip Lyons, President & CEO, Elizabeth Glaser Pediatric AIDS Foundation
H.E. Monica Geingos, First Lady, Republic of Namibia; Leadership Council Member, Concordia
William Weeks, Director, AI for Health Research, Microsoft

 

with lead programming partner

EGPAFLogo Horiz ColorFrame RGB - Now is the Time: Last Mile Challenges to Close the Global Health Equity Gaps for Children

“It absolutely is possible to end AIDs for children on the continent.” 

– H.E. Monica Geingos

“HIV and AIDS are going to persist if our services aren’t sustained and attention lost. We can’t let that happen.” 

– Chip Lyons

“AI can be tremendously helpful in expanding the provider workforce in resource-limited settings.” 

– William Weeks

“What will help close the last mile is not going to be the technology; it’s going to be the commitment to rethinking how we engage in the healthcare process today.” 

– Daniel Diasio

Key takeaways & next steps:

  • It’s crucial to maintain continuous efforts in the fight against HIV and AIDS. Prematurely declaring victory can lead to complacency, which may result in a resurgence of the virus.
  • Public health initiatives should prioritize innovation. The HIV and AIDS landscape evolves, and new challenges emerge. To stay effective, programs must adapt, explore new strategies, and embrace technological advancements, such as artificial intelligence (AI), to improve outcomes and address changing needs. 
  • Different regions have unique challenges and populations affected by HIV and AIDS. Tailoring responses to local contexts is essential. 
  • Reliable data is the foundation of effective healthcare, especially when leveraging AI. High-quality, disaggregated data is essential to inform decision-making, track progress, and target interventions effectively. Efforts should focus on improving data collection, accuracy, and accessibility to support AI-driven healthcare solutions.